Zoeken | Griddixdog

Subodh Adke toegevoegd een audio Networking
2026-05-05 12:09:56 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Reacties 0 aandelen 817 Views 0 voorbeeld

Please log in to like, share and comment!
Subodh Adke toegevoegd een audio Networking
2026-05-05 12:10:22 -

(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....

0 Reacties 0 aandelen 893 Views 0 voorbeeld

Please log in to like, share and comment!
Rutuja Deshmukh toegevoegd een audio Other
2026-07-02 07:39:33 -

Pharmaceutical CRO Market Competitive Analysis and Key Players
The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...

0 Reacties 0 aandelen 34 Views 0 voorbeeld

Please log in to like, share and comment!
Subhayan Mayra toegevoegd een audio Other
2026-05-26 12:44:21 -

AI Clinical Trial Market Growing at 15% CAGR Through 2034
According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...

0 Reacties 0 aandelen 960 Views 0 voorbeeld

Please log in to like, share and comment!